Lung Cancer Considered

Lung Cancer Considered

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. Lung Cancer considered is funded in part by Current sponsors: • AbbVie • AstraZeneca • Gilead • J&J • Summit

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(393)

Biomarkers in Lung Cancer: Barriers to Implementation

Biomarkers in Lung Cancer: Barriers to Implementation

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 which found that one-third of oncologists were unaware of evidence-based guidelines for these tests. To di...

16 Helmi 202445min

LCC in Cantonese Chinese: Barriers to Biomarker Testing

LCC in Cantonese Chinese: Barriers to Biomarker Testing

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a ...

16 Helmi 202439min

LCC in Mandarin Chinese: Barriers to Biomarker Testing

LCC in Mandarin Chinese: Barriers to Biomarker Testing

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 which found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a...

16 Helmi 202428min

LCC in French: Barriers to Biomarker Testing

LCC in French: Barriers to Biomarker Testing

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for biomarker tests. To reac...

16 Helmi 202439min

LCC in French Canadian: Barriers to Biomarker Testing

LCC in French Canadian: Barriers to Biomarker Testing

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a ...

16 Helmi 202445min

LCC in Portuguese: Barriers to Biomarker Testing

LCC in Portuguese: Barriers to Biomarker Testing

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a ...

16 Helmi 202436min

LCC in Japanese: Barriers to Biomarker Testing

LCC in Japanese: Barriers to Biomarker Testing

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To promote ...

14 Helmi 202433min

LCC in Spanish: Barriers to Biomarker Testing

LCC in Spanish: Barriers to Biomarker Testing

Today, IASLC released its 2024 Biomarker Survey, following up on its survey conducted in 2019 that found one-third of oncologists were unaware of evidence-based guidelines for these tests. To reach a ...

10 Helmi 202438min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
utelias-mieli
hippokrateen-vastaanotolla
filocast-filosofian-perusteet
rss-ammamafia
rss-tiedetta-vai-tarinaa
docemilia
tiedekulma-podcast
ihanat-ipanat
radio-antro
rss-bios-podcast
rss-vaasan-yliopiston-podcastit
rss-duodecim-lehti
rss-hereilla
rss-totuuden-liepeilla